Skip to main content
Caplight Logo









Azuca

Azuca

Private
New York City, New YorkHealthcare & Life Scienceshttps://azuca.co

Last Round

Series A

Dec 21, 2022

Total Funding Raised

$5.71M

Company Overview

Azuca operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in December 2022.

Azuca is an applied biotechnology company that provides a patent-pending infusion process, AZUCA TiME INFUSION®, which makes cannabinoids fast-acting, water-friendly, and stable for use in edible and beverage products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Azuca Comparables

Compare Azuca with similar companies based on industry and business-model similarity.

Azuca comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vertosa
89%
SōRSE Technology
86%
Nano Hemp Tech Labs
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Azuca Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 21, 2022
SeedMay 30, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ronald Silver

Founder Chief Creative Officer

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 21, 2022

    $4.2M round completed.

Book a demo to see all signals

For institutional investors. Book with your work email.

Azuca Filings

Explore SEC and related filing metadata, where available.

Azuca filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Azuca's valuation, stock price, and market status.

Is Azuca a public or private company?

Azuca is a private company.

What is the current stock price of Azuca?

Azuca is a private company, so its shares have no public market price. Caplight tracks Azuca's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Azuca worth (valuation)?

Valuation information for Azuca is not publicly available.

Can I buy Azuca stock?

Azuca shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Azuca's last funding round?

Azuca's most recent funding round was Series A on December 21, 2022.

Who are the main investors in Azuca?

Investor information for Azuca is not publicly disclosed.

Will Azuca IPO soon?

No public IPO plans have been announced for Azuca.

How can I track Azuca secondary market activity?

Caplight tracks bids, offers, and trades in Azuca's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range14
Year Founded2018
Last FundingDec 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?